Study Supports Tamoxifen for DCIS Early Breast Cancers

MONDAY, Dec. 16, 2024 -- The established hormone therapy drug tamoxifen can significantly decrease the risk of cancer recurring in women with an early, low-risk form of breast cancer, a new study says.

Women who took tamoxifen after undergoing a...